Search Within

Weinberg Fellows

Formats
  1. Meeting Abstract (1256)
  2. Journal Article (1061)
  3. Review (108)
  4. Editorial (54)
  5. Research Letter (31)
  6. Book Section (22)
  7. Correspondence (20)
  8. Guidelines (12)
  9. Conference Paper (2)
  10. Miscellaneous (1)
Groups
  1. Department of Medicine (2470)
  2. Solid Tumor Oncology Division (1885)
  3. Hematologic Malignancies, Division of (1191)
  4. GSK Faculty (1125)
  5. Department of Pathology and Laboratory Medicine (917)
  6. Epidemiology and Biostatistics (863)

More Groups

People
  1. Michael Berger (215)
  2. Marc Ladanyi (191)
  3. Pedram Razavi (184)
  4. Michael Offin (173)
  5. David Solit (166)
  6. Maria Carlo (166)

More People

Years
  1. 2025 (152)
  2. 2024 (370)
  3. 2023 (292)
  4. 2022 (347)
  5. 2021 (307)
  6. 2020 (307)

More Years

Publications
  1. Journal of Clinical Oncology (547)
  2. Blood (248)
  3. Annals of Oncology (98)
  4. Clinical Cancer Research (95)
  5. Journal of Thoracic Oncology (82)
  6. Cancer Research (80)

More Publications

Publishers
  1. American Society of Clinical Oncology (618)
  2. Elsevier Inc. (355)
  3. American Society of Hematology (282)
  4. American Association for Cancer Research (217)
  5. Nature Publishing Group (177)
  6. Oxford University Press (147)

More Publishers

Results (2567)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Durable response after olaparib treatment for perihilar cholangiocarcinoma with germline BRCA2 mutation
    Journal Article

    Costa, B. A.; Tallón de Lara, P.; Park, W.; Keane, F.; Harding, J. J.; Khalil, D. N.
    Oncology Research and Treatment (2023)

    Fulltext@MSK | Save
  • Camonsertib in DNA damage response-deficient advanced solid tumors: Phase 1 trial results
    Journal Article

    Yap, T. A.; Fontana, E.; Lee, E. K.; Spigel, D. R.; Højgaard, M.; Lheureux, S.; Mettu, N. B.; Carneiro, B. A.; Carter, L.; Plummer, R.; more...
    Nature Medicine (2023)

    Fulltext@MSK | Save
  • Integration of clinical sequencing and immunohistochemistry for the molecular classification of endometrial carcinoma
    Journal Article

    Rios-Doria, E.; Momeni-Boroujeni, A.; Friedman, C. F.; Selenica, P.; Zhou, Q.; Wu, M.; Marra, A.; Leitao, M. M. Jr; Iasonos, A.; Alektiar, K. M.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • A phase II study of epacadostat and pembrolizumab in patients with advanced sarcoma
    Journal Article

    Kelly, C. M.; Qin, L. X.; Whiting, K. A.; Richards, A. L.; Avutu, V.; Chan, J. E.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Payer and provider solutions to utilization management challenges in the management of rare hematologic cancers
    Review

    Jabbour, E. J.; Bobolts, L. R.; Spinks, T. E.; Geyer, M. B.; Ebot-Tar, V. T.; Haumschild, R.
    American Journal of Managed Care (2023)

    Fulltext@MSK | Save
  • Clinicopathologic and genomic factors impacting efficacy of first-line chemoimmunotherapy in advanced NSCLC
    Journal Article

    Alessi, J. V.; Elkrief, A.; Ricciuti, B.; Wang, X.; Cortellini, A.; Vaz, V. R.; Lamberti, G.; Frias, R. L.; Venkatraman, D.; Fulgenzi, C. A. M.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Tumor-infiltrating lymphocyte therapy in melanoma: Facts to the future
    Review

    Warner, A. B.; Corrie, P. G.; Hamid, O.
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • A tumor-selective adenoviral vector platform induces transient antiphospholipid antibodies, without increased risk of thrombosis, in phase 1 clinical studies
    Journal Article

    Khalil, D. N.; Prieto González-Albo, I.; Rosen, L.; Lillie, T.; Stacey, A.; Parfitt, L.; Soff, G. A.
    Investigational New Drugs (2023)

    Fulltext@MSK | Save
  • Letter to the editor: Reply to Zhao, Wu, and Ma
    Correspondence

    Alessi, J. V.; Elkrief, A.; Ricciuti, B.; Schoenfeld, A. J.; Awad, M. M.
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Comprehensive analysis of germline drivers in endometrial cancer
    Journal Article

    Gordhandas, S.; Rios-Doria, E.; Cadoo, K. A.; Catchings, A.; Maio, A.; Kemel, Y.; Sheehan, M.; Ranganathan, M.; Green, D.; Aryamvally, A.; more...
    JNCI: Journal of the National Cancer Institute (2023)

    Fulltext@MSK | Save